Several studies had revealed the dysregulation of HLA-F-AS1 in cancers [48,49,50] while the transcript expression of HLA-F-AS1 was verified to be downregulated in lung adenocarcinoma (LAD) samples [49]. This evidence concerns the gene HLA-F and leukocyte adhesion deficiency.